Stay updated on Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial page
- Check2 days agoChange DetectedThe page’s platform revision/version indicator was updated from **v3.5.2** to **v3.5.3**, reflecting a general software release with no apparent change to the displayed clinical trial record details.SummaryDifference0.1%

- Check9 days agoChange DetectedA new revision entry, v3.5.2, was added to the history and the older v3.5.0 entry was removed.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedAdded version v3.5.0 to the history and removed version v3.4.3.SummaryDifference0.1%

- Check45 days agoChange DetectedA new Revision: v3.4.3 was added and Revision: v3.4.2 was removed from the page history.SummaryDifference0.1%

- Check73 days agoChange DetectedAdded a new revision entry (v3.4.2) and removed an older notice about government funding/operating status (v3.4.1) from the history page.SummaryDifference0.4%

- Check80 days agoChange DetectedA government funding notice banner was added and the page revision label updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial page.